Endep and Aldactone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Endep (amitriptyline hydrochloride) and Aldactone (spironolactone). Common drug interactions include abdominal pain among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Endep and Aldactone. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Endep?

Endep has active ingredients of amitriptyline hydrochloride. It is often used in fibromyalgia. eHealthMe is studying from 1,302 Endep users. Check the latest studies of Endep.

What is Aldactone?

Aldactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 46,063 Aldactone users. Check the latest studies of Aldactone.



On Aug, 05, 2026

13 people who take Endep and Aldactone together, and have interactions are studied.

Endep and Aldactone drug interactions.

What are the common drug interactions of Endep and Aldactone, by gender? *:

female:

  1. Abdominal pain
  2. Back pain
  3. Blood urea nitrogen/creatinine ratio increased
  4. Confusional state
  5. Epistaxis (bleed from the nose)
  6. Gamma-glutamyltransferase increased
  7. Gastroenteritis (inflammation of stomach and intestine)
  8. Haematochezia (passage of stools containing blood)
  9. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  10. Headache (pain in head)

male:

  1. Anaemia (lack of blood)
  2. Dyspnoea (difficult or laboured respiration)
  3. Surgery
  4. Tricuspid valve incompetence (inefficient heart valve)
  5. Weight decreased
  6. Oedema peripheral (superficial swelling)
  7. Alcohol problem
  8. Cardiac failure
  9. Encephalopathy (functioning of the brain is affected by some agent or condition)
  10. Mitral valve incompetence (inefficient heart valve)

What are the common drug interactions of Endep and Aldactone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Epistaxis (bleed from the nose)
  2. Haematochezia (passage of stools containing blood)
  3. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  4. Inflammation
  5. Irritable bowel syndrome
  6. Overweight
  7. Rash
  8. Vaginal haemorrhage (vaginal bleeding)
  9. Haemorrhage (bleeding)
  10. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal pain
  2. Back pain
  3. Anaemia (lack of blood)
  4. Breast cancer
  5. Cardiovascular disorder (heart diseases)
  6. Coronary artery bypass
  7. Cough
  8. Disease recurrence
  9. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Joint Pain: 4 people, 30.77%
  2. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 23.08%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 23.08%
  4. Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 15.38%
  5. Cardiac Failure: 2 people, 15.38%
  6. Cardiomyopathy (weakening of the heart muscle): 2 people, 15.38%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 15.38%
  8. Constipation: 2 people, 15.38%
  9. Discomfort: 2 people, 15.38%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Endep and Aldactone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Endep and Aldactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Endep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aldactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Endep and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aldactone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on amitriptyline hydrochloride and spironolactone (the active ingredients of Endep and Aldactone, respectively), and Endep and Aldactone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: